Astrana Health (ASTH) furnishes updated January 2026 investor presentation

Rhea-AI Filing Summary

Astrana Health, Inc. furnished an updated corporate investor presentation that it plans to use at conferences and meetings. The slide deck, dated January 2026, is attached as Exhibit 99.1 and is provided for informational purposes only.

The company states that this material is being furnished rather than filed, which means it is not subject to certain liability provisions under securities laws and will not automatically be incorporated into other regulatory filings. The presentation contains forward-looking statements, and Astrana Health refers readers to its most recent annual and quarterly reports for a discussion of risks that could cause actual results to differ.

false 0001083446 0001083446 2026-01-12 2026-01-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 12, 2026

ASTRANA HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	001-37392	95-4472349
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801

(Address of Principal Executive Offices) (Zip Code)

(626) 282-0288

Registrant’s Telephone Number, Including Area Code

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	ASTH	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01 Regulation FD Disclosure.

On January 12, 2026, Astrana Health, Inc. (the “Company”) updated its corporate presentation that it intends to use in connection with presentations at conferences and meetings. The slides from the Company’s corporate presentation are attached as Exhibit 99.1 to this Current Report on Form 8-K and are incorporated herein by reference. The Company does not undertake to update the information contained in the attached presentation materials.

The information contained in this Current Report on Form 8-K, including the exhibit referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Investor Presentation (January 2026).
104		Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. These statements include words such as “forecast,” “guidance,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” or “will,” or the negative of these words or similar words. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including the factors described in the Company’s filings with the Securities and Exchange Commission, including the Company’s last Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ASTRANA HEALTH, INC.
Date: January 12, 2026	By:	/s/ Brandon K. Sim
	Name:	Brandon K. Sim
	Title:	Chief Executive Officer and President

FAQ

What did Astrana Health (ASTH) disclose in this 8-K filing?

Astrana Health furnished an updated corporate investor presentation it intends to use at conferences and meetings. The slide deck is attached as Exhibit 99.1 and is labeled as an investor presentation dated January 2026.

Is Astrana Healths new investor presentation considered filed with the SEC?

No. Astrana Health specifies that the information in this report, including the investor presentation, is being furnished and not deemed filed for purposes of Section 18 of the Exchange Act, and it will not be incorporated by reference into other Securities Act or Exchange Act filings.

Does the Astrana Health (ASTH) investor presentation include forward-looking statements?

Yes. The company states that the report contains forward-looking statements using terms such as forecast, guidance, expects, and similar words. It notes that actual results may differ materially due to various factors described in its most recent Form 10-K and subsequent Form 10-Q filings.

Where can investors find the updated Astrana Health (ASTH) investor presentation?

The updated investor presentation is included as Exhibit 99.1 to this report and is described as an Investor Presentation (January 2026). It is available through the companys SEC filings.

Does Astrana Health commit to updating the information in the January 2026 investor presentation?

No. Astrana Health explicitly states that it does not undertake to update the information contained in the attached presentation materials, even if new information or future events occur.

Who signed the Astrana Health (ASTH) report that furnished the investor presentation?

The report was signed on behalf of Astrana Health, Inc. by Brandon K. Sim, who is identified as the companys Chief Executive Officer and President.